PanelApp
Panels
Genes and Entities
Activity
Log in
Register
Genes and Genomic Entities
Q4_23_promote_green
211 genes and genomic entities tagged
“Q4_23_promote_green”
Find a gene or genomic entity
Gene or Genomic Entity Name
Enter a gene symbol, STR name, Region name, or the beginning of one, eg “CD” or “CD19”
211 genes and genomic entities
Show
Genes
STRS
Regions
ABHD5
ACACA
ACTC1
ADAMTS13
AGO1
ALG5
ALG8
ALG9
ANK3
AP2S1
APOA1
APOA2
APOC2
APOE
APRT
ARF3
ARHGAP35
ARX
ASL
ATP1A1
ATP5E
ATP6V0A4
ATP6V1B1
ATRIP
AVPR2
AXIN1
BAP1
BLOC1S5
BMPR1B
BUB1
CA2
CASP2
CASR
CBLB
CD151
CD4
CD81
CDK16
CDKN2A
CDSN
CFAP20
CFHR2
CLCN6
CLCNKB
CLDN10
CLDN11
CLDN16
CLDN19
CNNM2
COL4A1
COL4A2
COX11
COX5A
CR2
CRYBB2
CSTA
CTNND1
CTSF
CUL3
CUL4B
CXCR2
CYP24A1
DAAM2
DLG4
DLG5
DNAJC7
DUT
EDEM3
EPHA2
ERG
ERI1
ESAM
FAH
FAM20A
FBXW11
FGA
FKRP
FLCN
FLG2
FN1
FOXJ1
GNA11
GOLGA2
GON7
GPIHBP1
GREM1
GRN
GSN
HADHB
HBA2
HBG1
HBG2
HECTD4
HMOX1
HNF4A
HPRT1
HSPA9
HYOU1
IFT140
IFT172
IFT27
IL23R
IRF2BP2
IRF4
JAK1
KCNJ1
KCNJ10
KCNJ16
KDM6A
KIAA0586
KIF11
KLHL3
KMT2B
KRT81
KRT86
LCAT
LMF1
LTBP2
LYN
LYZ
MAGED2
MAST4
MCTS1
MECOM
MECP2
MOCOS
MRM2
MVK
MYF5
MYH10
NEK8
NFAT5
NLRP1
NME5
NOTCH3
NR3C2
NSD2
NUP188
NUS1
PDSS2
PHEX
PIGM
PLA2G6
PMEPA1
PNPLA2
POLD1
PPFIBP1
PPP1R13L
PRKCSH
PROP1
PSMB10
PSMC3
PTCD3
PTPN2
RANBP2
RAP1B
RBL2
REL
RELA
RETREG1
RHOA
RMND1
RRAGD
SAMD9L
SARS
SARS2
SCNN1A
SCNN1B
SCNN1G
SEC61A1
SEC63
SERPINB8
SHQ1
SLC12A1
SLC12A3
SLC12A6
SLC25A24
SLC25A36
SLC2A2
SLC34A1
SLC34A3
SLC4A1
SLC4A4
SLC52A2
SLC52A3
SLC5A2
SMG8
SPEF2
SPI1
SRSF1
STAT6
STRADA
TAMM41
TEFM
TFRC
TGM5
THG1L
TPRKB
TRAF3IP2
TRIT1
TRPM6
TTR
TULP3
UBA2
VCP
VPS16
VPS33A
WDR72
WNK4
YRDC
ZBTB47
Tagged
adult-onset
adverse-drug-reaction
age-specific-variation
anticipation
Autism Spectrum Disorder
CBLIF
CFAP298
CFAP300
chimeric-gene
clinical_reviewed
cnv
curated_removed
curated-variant-list
currently-ngs-unreportable
CYBC1
deletions
de novo
DIFF
differe
different_gene_name
digenic
discretionary
disputed
DNAAF11
DNAAF6
dominant-negative
drug-contraindication
drug-dosing
drug-efficacy
drug-indication
drug-toxicity
early-onset
ensembl_ids_known_missing
epigenetics
for-review
founder-effect
G6PC1
GBA1
gene-checked
gene_duplication
gene-duplication
gene-therapy-trial
GOF
GOF/LOF
HJV
IARS1
internal_inclusion_list_only
LARS1
limit of detection for heteroplasmic variants is not validated for WGS testing
locus-type-phenotype-only
locus-type-pseudogene
locus-type-rna-long-non-coding
locus-type-rna-micro
locus-type-rna-misc
locus-type-rna-ribosomal
locus-type-rna-small-nuclear
locus-type-rna-transfer
locus-type-rna-vault
locus-type-small-nucleolar
locus-type-unknown
LOF/dominant-negative
MARS1
microdeletion
microduplication
missense
MMUT
monogenic - polygenic
monogenic-polygenic
mosaicism
multifactorial
new-
new-gene-name
ngs-false-positive-region
NGS Not Validated
non-coding-known-pathogenic
nucleotide-repeat-expansion
ODAD1
ODAD2
ODAD3
ODAD4
pathogenic-synonymous
pharmacogenetics
polygenic
prognosis
promoter
Pseudoautosomal region 1
Pseudoautosomal region 2
Q1_22_expert_review
Q1_22_MOI
Q1_22_NHS_review
Q1_22_phenotype
Q1_22_rating
Q1_234
Q1_23_demote_amber
Q1_23_demote_grey
Q1_23_demote_red
Q1_23_expert_review
Q1_23_MOI
Q1_23_MOP_not_LOF
Q1_23_MOP_other
Q1_23_NHS_review
Q1_23_promote_green
Q1_24_demote_amber
Q1_24_demote_red
Q1_24_expert_review
Q1_24_MOI
Q1_24_NHS_review
Q1_24_phenotype
Q1_24_promote_green
Q2_21_expert_review
Q2_21_MOI
Q2_21_NHS_review
Q2_21_phenotype
Q2_21_rating
Q2_22_expert_review
Q2_22_MOI
Q2_22_NHS_review
Q2_22_phenotype
Q2_22_rating
Q2_23_demote_amber
Q2_23_demote_grey
Q2_23_demote_red
Q2_23_expert_review
Q2_23_MOI
Q2_23_NHS_review
Q2_23_promote_green
Q2_24_demote_amber
Q2_24_demote_red
Q2_24_expert_review
Q2_24_MOI
Q2_24_NHS_review
Q2_24_promote_green
Q3_21_expert_review
Q3_21_MOI
Q3_21_NHS_review
Q3_21_phenotype
Q3_21_rating
Q3_22_expert_review
Q3_22_MOI
Q3_22_NHS_review
Q3_22_phenotype
Q3_22_rating
Q3_23_demote_amber
Q3_23_demote_red
Q3_23_expert_review
Q3_23_MOI
Q3_23_NHS_review
Q3_23_phenotype
Q3_23_promote_green
Q4_21_expert_review
Q4_21_MOI
Q4_21_NHS_review
Q4_21_phenotype
Q4_21_rating
Q4_22_demote_amber
Q4_22_demote_grey
Q4_22_demote_red
Q4_22_expert_review
Q4_22_MOI
Q4_22_MOP_not_LOF
Q4_22_MOP_other
Q4_22_NHS_review
Q4_22_promote_green
Q4_23_demote_amber
Q4_23_demote_red
Q4_23_expert_review
Q4_23_MOI
Q4_23_NHS_review
Q4_23_promote_green
Q4_24_expert_review
recurrent-variant
refuted
regulatory-region
removed
SARS1
Schizophrenia
single-deletion
Skewed X-inactivation
SKIC2
SKIC3
somatic
special_caller_only
STR
stratified-medicine
structural-variant
sva
TAFAZZIN
to_be_confirmed_NHSE
treatable
trinucleotide-repeat-expansion
watchlist
watchlist_moi
x-linked-over-dominance
y-chromosome